Effects of chemogenetic inhibition of serotonergic raphe-striatal neurons on L-DOPA-induced behaviors and neurochemistry in a rat model of Parkinson’s disease
Authors:
Open Access
- 11 March 2026
- journal article
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 14 (1)
Abstract
The online version contains supplementary material available at 10.1186/s40478-026-02221-1. The online version contains supplementary material available at 10.1186/s40478-026-02221-1.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01NS122226)
- National Institute of Neurological Disorders and Stroke (R01NS122226)
- National Institute of Neurological Disorders and Stroke (R01NS122226)
This publication has 156 references indexed in Scilit:
- Diverse serotonin actions of vilazodone reduce l‐3,4‐dihidroxyphenylalanine–induced dyskinesia in hemi‐parkinsonian ratsMovement Disorders, 2018
- Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's diseaseJournal of Neuroscience Research, 2016
- Chemogenetics—A Transformational and Translational PlatformJAMA Neurology, 2015
- Pathogenesis of Parkinson's diseaseMovement Disorders, 2012
- Maladaptive plasticity of serotonin axon terminals in levodopa‐induced dyskinesiaAnnals of Neurology, 2010
- Parkinson's disease symptoms: The patient's perspectiveMovement Disorders, 2010
- Serotonin and Parkinson's disease: On movement, mood, and madnessMovement Disorders, 2009
- Contribution of the striatum to the effects of 5‐HT1A receptor stimulation in L‐DOPA‐treated hemiparkinsonian ratsJournal of Neuroscience Research, 2008
- Dual serotoninergic projections to forebrain in the rat: Morphologically distinct 5‐HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivativesJournal of Comparative Neurology, 1991
- Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkeyJournal of Comparative Neurology, 1990